![]()
|
|
||||||||
(Received for publication, May 31, 1995) A mathematical model has been developed to simulate the
generation of thrombin by the tissue factor pathway. The model gives
reasonable predictions of published experimental results without the
adjustment of any parameter values. The model also accounts explicitly
for the effects of serine protease inhibitors on thrombin generation.
Simulations to define the optimum affinity profile of an inhibitor in
this system indicate that for an inhibitor simultaneously potent
against VIIa, IXa, and Xa, inhibition of thrombin generation decreases
dramatically as the affinity for thrombin increases. Additional
simulations show that the reason for this behavior is the sequestration
of the inhibitor by small amounts of thrombin generated early in the
reaction. This model is also useful for predicting the potency of
compounds that inhibit thrombosis in rats. We believe that this is the
first mathematical model of blood coagulation that considers the
effects of exogenous inhibitors. Such a model, or extensions thereof,
should be useful for evaluating targets for therapeutic intervention in
the processes of blood coagulation.
Volume 270,
Number 43,
Issue of October 27, 1995 pp. 25383-25387
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Nagashima Studies on the Different Modes of Action of the Anticoagulant Protease Inhibitors DX-9065a and Argatroban. I. EFFECTS ON THROMBIN GENERATION J. Biol. Chem., December 20, 2002; 277(52): 50439 - 50444. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |